EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 221 filers reported holding EDITAS MEDICINE INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $422,616 | -37.8% | 90,496 | -1.2% | 0.00% | -40.0% |
| Q1 2024 | $679,902 | -25.8% | 91,631 | +1.3% | 0.01% | -28.6% |
| Q4 2023 | $916,147 | +30.2% | 90,439 | +0.2% | 0.01% | +16.7% |
| Q3 2023 | $703,825 | -5.1% | 90,234 | +0.1% | 0.01% | 0.0% |
| Q2 2023 | $741,638 | +14.2% | 90,114 | +0.6% | 0.01% | 0.0% |
| Q1 2023 | $649,230 | -9.3% | 89,549 | +11.0% | 0.01% | -14.3% |
| Q4 2022 | $715,871 | -27.0% | 80,707 | +0.8% | 0.01% | -36.4% |
| Q3 2022 | $980,000 | +4.8% | 80,069 | +1.3% | 0.01% | +22.2% |
| Q2 2022 | $935,000 | -37.3% | 79,065 | +0.8% | 0.01% | -30.8% |
| Q1 2022 | $1,492,000 | -20.6% | 78,443 | +10.8% | 0.01% | -7.1% |
| Q4 2021 | $1,879,000 | -35.4% | 70,776 | +0.0% | 0.01% | -39.1% |
| Q3 2021 | $2,907,000 | -24.6% | 70,755 | +3.9% | 0.02% | -28.1% |
| Q2 2021 | $3,856,000 | +59.3% | 68,080 | +18.1% | 0.03% | +45.5% |
| Q1 2021 | $2,421,000 | – | 57,640 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 6,000,000 | $28,020,000 | 0.84% |
| Knott David M Jr | 177,000 | $827 | 0.33% |
| Integral Health Asset Management, LLC | 675,000 | $3,152,250 | 0.30% |
| Avidity Partners Management LP | 816,000 | $3,810,720 | 0.16% |
| Green Alpha Advisors, LLC | 30,267 | $141,347 | 0.11% |
| PDT Partners, LLC | 246,537 | $1,151,328 | 0.11% |
| Spectrum Planning & Advisory Services Inc. | 12,051 | $57,122 | 0.06% |
| Woodline Partners LP | 970,491 | $4,532,193 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 168,371 | $786,293 | 0.04% |
| Virtus ETF Advisers LLC | 16,489 | $77,004 | 0.04% |